Transparency requirements under the French Sunshine Act: life sciences companies in the dark?
The implementing decree giving full effect to the French ‘Sunshine Act’ requires life sciences companies to disclose specifically listed information regarding agreements with, and benefits as of €10 to, a wide range of healthcare actors. Awaiting the establishment of a single public website to be created for that purpose, the information must be published on the companies’ websites (or a website of a group of companies) and — when concerning healthcare professionals or students — the website of the relevant healthcare professionals’ order. The information must remain available for a period of five years.
Immediate action is required, in particular with regard to information on agreements and benefits involving healthcare professionals or students (or their respective associations). Such information, for the year of 2012, had to be submitted to the National Council of the respective orders by 1 June 2013; information related to the first calendar half of 2013 is due by 1 August 2013. Companies have a little more time to adjust their websites for purposes of the required disclosure as the publication deadline for the information on agreements and benefits entered into, or granted between, 1 January 2012 and 30 June 2013 is set at 1 October of this year.
Non-compliance with these transparency requirements may subject life sciences companies to a criminal fine of up to €225,000. The decree also contains further specifications related to the anti-gift statute, as implemented in Article L. 4113-6 of the Public Health Code (PHC), which are not further discussed in this e-alert…
If you are registered and logged in to the site, click on the link below to read the rest of the Allen & Overy briefing. If not, please register or sign in with your details below.
News from Allen & Overy
News from The Lawyer
Briefings from Allen & Overy
The ITC has reaffirmed its power to ban electronic transmissions from the US where those transmissions infringe an intellectual property right or are otherwise based on an unfair trade practice.
A new French law, the ‘Law to recapture the real economy’ (‘Loi visant à reconquérir l’économie réelle’ or ‘Loi Florange’), was made on 1 April 2014.
Analysis from The Lawyer
Imagine you’re the general counsel of London-based private equity investor BC Partners. You’re sipping on your coffee, hashing out the details of your imminent £382m investment into UK-based business publishing company Mergermarket.
‘Exotic’ investors and opportunities for legal work beyond M&A feature in The Lawyer’s high-level roundtable debate on south-east Europe